1. Home
  2. OLMA vs WSBF Comparison

OLMA vs WSBF Comparison

Compare OLMA & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • WSBF
  • Stock Information
  • Founded
  • OLMA 2006
  • WSBF 1921
  • Country
  • OLMA United States
  • WSBF United States
  • Employees
  • OLMA N/A
  • WSBF N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • WSBF Savings Institutions
  • Sector
  • OLMA Health Care
  • WSBF Finance
  • Exchange
  • OLMA Nasdaq
  • WSBF Nasdaq
  • Market Cap
  • OLMA 299.7M
  • WSBF 240.7M
  • IPO Year
  • OLMA 2020
  • WSBF N/A
  • Fundamental
  • Price
  • OLMA $4.20
  • WSBF $13.46
  • Analyst Decision
  • OLMA Strong Buy
  • WSBF
  • Analyst Count
  • OLMA 4
  • WSBF 0
  • Target Price
  • OLMA $24.50
  • WSBF N/A
  • AVG Volume (30 Days)
  • OLMA 868.7K
  • WSBF 45.6K
  • Earning Date
  • OLMA 08-05-2025
  • WSBF 07-24-2025
  • Dividend Yield
  • OLMA N/A
  • WSBF 4.46%
  • EPS Growth
  • OLMA N/A
  • WSBF 95.86
  • EPS
  • OLMA N/A
  • WSBF 1.02
  • Revenue
  • OLMA N/A
  • WSBF $133,551,000.00
  • Revenue This Year
  • OLMA N/A
  • WSBF N/A
  • Revenue Next Year
  • OLMA N/A
  • WSBF N/A
  • P/E Ratio
  • OLMA N/A
  • WSBF $13.23
  • Revenue Growth
  • OLMA N/A
  • WSBF 1.81
  • 52 Week Low
  • OLMA $2.86
  • WSBF $11.61
  • 52 Week High
  • OLMA $16.62
  • WSBF $16.86
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 43.60
  • WSBF 60.02
  • Support Level
  • OLMA $3.90
  • WSBF $13.21
  • Resistance Level
  • OLMA $4.29
  • WSBF $13.88
  • Average True Range (ATR)
  • OLMA 0.36
  • WSBF 0.20
  • MACD
  • OLMA -0.03
  • WSBF -0.00
  • Stochastic Oscillator
  • OLMA 19.18
  • WSBF 64.10

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.

Share on Social Networks: